by plexusventures_h3tnl0 | May 5, 2023 | Uncategorized
Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”). The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...
by plexusventures_h3tnl0 | Feb 17, 2023 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of an out-licensing project conducted on behalf of its client, Elthera AG of Switzerland. Plexus Ventures served as the exclusive business development advisor to Elthera in...
by plexusventures_h3tnl0 | Dec 2, 2022 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...
by plexusventures_h3tnl0 | Jun 7, 2022 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures, a prominent corporate and business development boutique for healthcare companies, is pleased to announce our newest Managing Director. The Partners at Plexus Ventures are very pleased to announce that Ahmed Al-Derzi has...
Recent Comments